Call Number (LC) Title Results
HE 1.75:OEI-05-10-00240 Most early Head Start teachers have the required credentials but challenges exist. 1
HE 1.75:OEI-05-10-00450 Gaps in oversight of conflicts of interest in Medicare prescription drug decisions. 1
HE 1.75:OEI-05-11-00130 Medicaid third-party liability savings increased, but challenges remain. 1
HE 1.75:OEI-05-11-00140 Memorandum report : Administration for Children and Families strengthened its oversight of Head Start eligibility in fiscal year 2011 /
Memorandum report : ACF strengthened its oversight of Head Start eligibility in fiscal year 2011. 		2
HE 1.75:OEI-05-11-00250 Early assessment finds that CMS faces obstacles in overseeing the Medicare EHR incentive program. 1
HE 1.75:OEI-05-11-00580 Medicaid drug rebate dispute resolution could be improved. 1
HE 1.75:OEI-05-12-00080 Most critical access hospitals would not meet the location requirements if required to re-enroll in Medicare. 1
HE 1.75:OEI-05-12-00081 Services provided at critical access hospitals in 2011. 1
HE 1.75:OEI-05-12-00085 Medicare beneficiaries paid nearly half of the costs for outpatient services at critical access hospitals. 1
HE 1.75:OEI-05-12-00340 Questionable billing for polysomnography services. 1
HE 1.75:OEI-05-12-00480 Medicare and beneficiaries could realize substantial savings If the DRG window were expanded. 1
HE 1.75:OEI-05-12-00540 Manufacturer safeguards may not prevent copayment coupon use for Part D drugs. 1
HE 1.75:OEI-05-12-00610 Early outcomes show limited progress for the transformed Medicaid Statistical Information System. 1
HE 1.75:OEI-05-13-00290 CMS has yet to enforce a statutory provision related to rural health clinics. 1
HE 1.75:OEI-05-13-00431 Memorandum report : contract pharmacy arrangements in the 340B Program. 1
HE 1.75:OEI-05-13-00520 Medicaid enhanced provider enrollment screenings have not been fully implemented. 1
HE 1.75:OEI-05-13-00690 Recommendation followup memorandum report : CMS needs to do more to improve Medicaid children's utilization of preventive screening services. 1
HE 1.75:OEI-05-14-00430 State efforts to exclude 340B drugs from Medicaid managed care rebates. 1
HE 1.75:OEI-05-14-00431 Recommendation followup memorandum report : states' collection of rebates for drugs paid through Medicaid managed care organizations has improved.
Recommendation followup memorandum report : states' collection of rebates for drugs paid through medicaid managed care organizations has improved. 		2
HE 1.75:OEI-05-15-00120 Memorandum report : Part D plans generally include drugs commonly used by dual eligibles. 1